Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological characterization of GSK1004723, a novel, long-acting antagonist at histamine H(1) and H(3) receptors.

British journal of pharmacology·2011
Same author

Temporal and spatial patterns of sea lice levels on sea trout in western Scotland in relation to fish farm production cycles.

Biology letters·2010
Same author

Polymorphisms in the endothelin-1 (EDN1) are associated with asthma in two populations.

Genes and immunity·2007
Same author

Potential pathophysiological role of endothelin-1 in asthma.

Drug news & perspectives·2004
Same author

Interleukin-8 receptor antagonists in pulmonary diseases.

Current opinion in pharmacology·2001
Same author

Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.

Journal of medicinal chemistry·2001

Related Experiment Video

Updated: May 25, 2026

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
13:45

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

Cysteinyl leukotriene receptor assays.

R M Muccitelli1, M A Luttmann, D W Hay

  • 1SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania, USA.

Current Protocols in Pharmacology
|February 2, 2012
PubMed
Summary

This study details methods for measuring contractile responses to cysteinyl leukotrienes (CysLTs) in smooth muscle. These techniques are crucial for understanding inflammatory diseases like asthma.

Area of Science:

  • Pharmacology
  • Physiology
  • Biochemistry

Background:

  • Cysteinyl leukotrienes (CysLTs), including LTC4, LTD4, and LTE4, are lipid mediators derived from arachidonic acid metabolism.
  • CysLTs play a significant role in the pathophysiology of inflammatory conditions, most notably asthma.

Purpose of the Study:

  • To describe standardized techniques for measuring contractile and relaxant responses to CysLTs in isolated smooth muscle preparations.
  • To provide a detailed methodology for assessing CysLT-induced contractions in guinea-pig trachea.
  • To highlight the adaptability of these methods for various airway and non-airway tissues across different species.

Main Methods:

  • Utilizes standard isometric measurement techniques for assessing contractile or relaxant responses of isolated tissues to exogenous agonists.

More Related Videos

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Related Experiment Videos

Last Updated: May 25, 2026

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
13:45

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Assessing Respiratory Immune Responses to Haemophilus Influenzae
06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

  • Outlines specific dissection and experimental protocols for guinea-pig trachea preparations.
  • Employs general methodology applicable to diverse animal airway tissues and non-airway tissues, such as the gastrointestinal tract.
  • Main Results:

    • Demonstrates the application of isometric tension measurement for evaluating CysLT activity in smooth muscle.
    • Provides a robust protocol for studying CysLT-mediated bronchoconstriction in a relevant animal model.
    • Confirms the broad applicability of the described methods for investigating CysLT effects in various biological systems, including relaxant responses.

    Conclusions:

    • The described methods provide a reliable framework for quantifying CysLT-induced smooth muscle contractility and relaxant effects.
    • These techniques are essential for advancing research into the role of CysLTs in inflammatory diseases like asthma.
    • The standardized methodology facilitates comparative studies across different tissues and species, enhancing our understanding of CysLT signaling pathways.